Return On Equity of Marker Therapeutics, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Marker Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Marker Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -92%, a 2.4% decline year-over-year.
  • Marker Therapeutics, Inc. annual Return On Equity for 2024 was -90%, a 80% decline from 2023.
  • Marker Therapeutics, Inc. annual Return On Equity for 2023 was -50%, a 56% increase from 2022.
  • Marker Therapeutics, Inc. annual Return On Equity for 2022 was -113%, a 57% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Marker Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -92% -2.1% -2.4% 01 Jul 2025 30 Sep 2025
Q2 2025 -115% -35% -44% 01 Apr 2025 30 Jun 2025
Q1 2025 -102% -65% -177% 01 Jan 2025 31 Mar 2025
Q4 2024 -90% -40% -80% 01 Oct 2024 31 Dec 2024
Q3 2024 -90% -38% -73% 01 Jul 2024 30 Sep 2024
Q2 2024 -79% -11% -16% 01 Apr 2024 30 Jun 2024
Q1 2024 -37% +79% +68% 01 Jan 2024 31 Mar 2024
Q4 2023 -50% +63% +56% 01 Oct 2023 31 Dec 2023
Q3 2023 -52% +58% +53% 01 Jul 2023 30 Sep 2023
Q2 2023 -69% +35% +34% 01 Apr 2023 30 Jun 2023
Q1 2023 -116% -28% -32% 01 Jan 2023 31 Mar 2023
Q4 2022 -113% -41% -57% 01 Oct 2022 31 Dec 2022
Q3 2022 -110% -35% -46% 01 Jul 2022 30 Sep 2022
Q2 2022 -103% -30% -41% 01 Apr 2022 30 Jun 2022
Q1 2022 -88% -13% -17% 01 Jan 2022 31 Mar 2022
Q4 2021 -72% +15% +17% 01 Oct 2021 31 Dec 2021
Q3 2021 -75% -7.4% -11% 01 Jul 2021 30 Sep 2021
Q2 2021 -73% -17% -30% 01 Apr 2021 30 Jun 2021
Q1 2021 -75% -26% -52% 01 Jan 2021 31 Mar 2021
Q4 2020 -87% -44% -102% 01 Oct 2020 31 Dec 2020
Q3 2020 -68% +216% +76% 01 Jul 2020 30 Sep 2020
Q2 2020 -56% +305% +84% 01 Apr 2020 30 Jun 2020
Q1 2020 -49% +452% +90% 01 Jan 2020 31 Mar 2020
Q4 2019 -43% +870% +95% 01 Oct 2019 31 Dec 2019
Q3 2019 -284% +379% +57% 01 Jul 2019 30 Sep 2019
Q2 2019 -361% +48% +12% 01 Apr 2019 30 Jun 2019
Q1 2019 -501% -251% -100% 01 Jan 2019 31 Mar 2019
Q4 2018 -913% -716% -364% 01 Oct 2018 31 Dec 2018
Q3 2018 -662% -503% -316% 01 Jul 2018 30 Sep 2018
Q2 2018 -409% -288% -238% 01 Apr 2018 30 Jun 2018
Q1 2018 -251% -284% -853% 01 Jan 2018 31 Mar 2018
Q4 2017 -197% -228% -729% 01 Oct 2017 31 Dec 2017
Q3 2017 -159% -176% -1026% 01 Jul 2017 30 Sep 2017
Q2 2017 -121% -1.4% -1.2% 01 Apr 2017 30 Jun 2017
Q1 2017 33% -74% -69% 01 Jan 2017 31 Mar 2017
Q4 2016 31% -77% -71% 01 Oct 2016 31 Dec 2016
Q3 2016 17% -107% -86% 01 Jul 2016 30 Sep 2016
Q2 2016 -120% -440% -137% 01 Apr 2016 30 Jun 2016
Q1 2016 107% +49% +85% 01 Jan 2016 31 Mar 2016
Q4 2015 109% -1159% -91% 01 Oct 2015 31 Dec 2015
Q3 2015 125% 01 Jul 2015 30 Sep 2015
Q2 2015 320% 01 Apr 2015 30 Jun 2015
Q1 2015 58% 01 Jan 2015 31 Mar 2015
Q4 2014 1267% 01 Oct 2014 31 Dec 2014
Q2 2012 108% 01 Apr 2012 30 Jun 2012
Q1 2012 49% 01 Jan 2012 31 Mar 2012

Marker Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -90% -40% -80% 01 Jan 2024 31 Dec 2024
2023 -50% +63% +56% 01 Jan 2023 31 Dec 2023
2022 -113% -41% -57% 01 Jan 2022 31 Dec 2022
2021 -72% +15% +17% 01 Jan 2021 31 Dec 2021
2020 -87% -44% -102% 01 Jan 2020 31 Dec 2020
2019 -43% +870% +95% 01 Jan 2019 31 Dec 2019
2018 -913% -716% -364% 01 Jan 2018 31 Dec 2018
2017 -197% -228% -729% 01 Jan 2017 31 Dec 2017
2016 31% -77% -71% 01 Jan 2016 31 Dec 2016
2015 109% -1159% -91% 01 Jan 2015 31 Dec 2015
2014 1267% 01 Jan 2014 31 Dec 2014
2012 132% 01 Jan 2012 31 Dec 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.